Striatal cell-type–specific molecular signatures reveal potential therapeutic targets in a model of dystonia.
Published in Neurobiology of Disease, 2025
DOPA-responsive dystonia
Recommended citation: Roman KM, Dinasarapu AR , Cherian S, Fan X, Donsante Y, Aravind N, Chan C,S, Jinnah HA, Hess EJ. Striatal cell-type–specific molecular signatures reveal potential therapeutic targets in a model of dystonia Neurobiology of Disease,(2025) https://doi.org/10.1016/j.nbd.2025.106981